Cross-border volume and revenue per case are growing in medical travel. Capacity is being added, and international patient departments are busy again in many locations. Yet almost every destination program now depends on conditions over which it has no control: a handful of air corridors, one or two source countries, a small set of referral intermediaries, visa regimes that change abruptly, and less political appetite for treating foreign patients than most executives would like to think.
Strong demand carried by a narrow, politically exposed delivery system is the pattern Jens Thraenhart calls the Next Tourism Order — the gap between a record year and the underlying factors like corridors, costs, and politics that are quietly rewriting it beneath the surface. His prescription for the wider travel economy is the one worth borrowing here: Build reserves while conditions are good, and rehearse for shocks ahead of time rather than reacting to them.*
Health travel needs this discipline even more than leisure travel — a deferred patient procedure is quite different from a deferred vacation booking. Surgery carries a clinical clock, a financial guarantee, an escort, a follow-up schedule, and a liability trail. Most hospitals and medical travel DMOs will say they take resilience seriously, but very few have internalized it, meaning it is not included in the budget, the board calendar, or executive incentives. Internalizing resilience needs to be an operating discipline, not a document that sits in the cloud or in a dusty binder.
Start with an honest audit
Resilience begins with understanding the reality of where your organization stands — especially in the face of a crisis. Here are four questions to get started, each to be answered with real numbers and honesty.
Concentration: What share of international patient revenue comes from your largest source country, largest referring agency or payer, and largest service line? If any one of these sources exceeds roughly a third (33%), that is a structural dependency, not a market position. Programs that fail in this decade will be those that have built an economy on one dependency assuming it would hold indefinitely.
Corridor: How do those patients physically arrive — which airports, carriers, visa statuses, and pre-authorization regimes? A single route suspension or new entry requirement can remove a quarter of inbound volume overnight.
Capital: Could your organization absorb two financial quarters of a 40% volume decline without cutting the subspecialists, the international patient office, or the digital front door? Those are the first assets that are cut in a panic — and cutting them is what turns a revenue dip into a longer-term capacity problem.
Trust: In a crisis, would domestic patients, your own clinicians, and the health ministry defend the international program — or use the moment to close it? A single story of foreign patients treated ahead of local ones during a shortage can end a program that survived a corridor closure and/or a revenue hit. Social license, once spent, is often far slower to rebuild than capacity or cash reserves.
Build your plan in three time-horizons
Next 90 days — instrument and stress-test.
- Build a dashboard of leading indicators rather than the lagging metric, i.e., arrivals. For example: inquiry-to-case conversion by source market, seat capacity and airfare on top corridors, visa and pre-authorization changes, currency movement, travel-advisory status, payer payment behavior, clinician turnover.
- Give it one executive owner and a monthly review slot.
- Then at least twice per year, run a half-day exercise on the two shocks most likely to hurt you — a corridor closure that reroutes your patients, and your largest source market closing the spigot — and make a concrete plan of the responsibilities of each team member within the first 72 hours. Consider it a stress-test for your system.
Next 12 months — Build the reserves.
- Demand: Add two credible source markets and one domestic or regional segment that can run on your existing clinical capacity — diversification that makes current assets more efficient, not a new cost base.
- Capital: Quantify a dedicated international-program reserve and decide in advance what it protects when volumes fall.
- Operations: Build redundancy into every enabler the patient journey depends on — two carrier and two facilitator options per corridor, modular volume commitments, telehealth-enabled pre- and post-operative pathways, and a documented rebooking and repatriation protocol.
- Trust: Publish local-benefit metrics — cross-subsidy, brand enhancement, clinician recruitment and retention, capacity improvements — before local media or anyone else demands them.
Beyond 12 months — govern it.
Put resilience on the board calendar, the capital plan, and the incentive structure — or it erodes.
- Review scenarios at board level at least twice a year.
- Tie part of executive incentives to concentration and reserve-diversification metrics rather than volume alone.
- Require every new corridor investment to come with an explicit dependency-risk assessment.
When to get outside help, and when to skip it
Most of this work is internal and should stay internal. However, here are three conditions when outside help may be warranted.
- The concentration number can be politically sensitive. The executive(s) who built the dependency on one source market may not want to admit how large it has grown, so a self-reported number is often too low. An independent, outside assessment can state the real number without putting the blame on any one person. If your team already discusses this number honestly and openly, you do not need outside help for this step.
- Diversification targets have no evidence base. Choosing new source markets requires comparative data on referral economics, price positioning, payer behavior, and competitor capacity, especially where you have no history. If your team is setting targets from conference conversations and inbound inquiries, your sample data is almost certainly biased. This is an example where outside data that is objectively sourced and independently vetted could help close that gap. If you already have reliable data on comparable markets, you don’t need outside help with this.
- Scenario work often ends up supporting the preferred future anyway. If every scenario validates the current strategy, the exercise isn’t working. Using an outside, objective facilitator for your scenario workshop can surface the uncomfortable issues, hold team members accountable, and push the team toward a real playbook — not just validation of the current state. If your scenarios already produce genuine disagreement and concrete action items, you do not need outside help here.
One caution. The real constraint is follow-through — dashboards nobody owns, contracts nobody reopens, governance that resets with each leadership change — outside engagement helps only at the margin. Ownership has to be inside, or the status quo prevails.
Organizations need to build resilience in the good years, before the year that tests it. That is the difference between a shock that moves market share toward you and one that removes you from the market.
* Jens Thraenhart, The Next Tourism Order: How Geopolitical Fragmentation Will Reshape Global Travel, 2026 to 2030, Revised Edition, Chameleon Strategies, 2026.